Table 1.
Novel epilepsy gene discoveries from 2012 to 2015
Gene | Phenotype(s) | Number of casesa | References |
---|---|---|---|
Chromatin remodeling | |||
CHD2 | EOEE, LGS, EE, ASD | >20 | [28, 44–46, 87] |
Ion channels and neurotransmitter receptors | |||
GABRA1 | DS, IS, JME, CAE, GGE | >10 | [42, 46, 88–90] |
GABRB3 | IS, LGS | 4 | [46] |
GRIN2A | LKS, CSWS, BECTS, ABPE, EE | >50 | [91–97] |
GRIN2B | IS, LGS, FE/ID, ID, ASD | >10 | [46, 49, 54, 98] |
HCN1 | EOEE | 4 | [40] |
KCNB1 | IS | 4 | [43, 68] |
KCNA2 | EE | 6 | [99] |
KCNC1 | PME | 13b | [100] |
KCNQ2 | BFNS, EOEE, EE | >50 | [9, 72, 101–104] |
KCNT1 | MPSI, ADNFLE | 14 | [81, 105–108] |
SCN8A | EE, EOEE | >30 | [35, 37–39, 108] |
SLC6A1 | MAE | 6 | [30] |
Intracellular signaling | |||
GNAO1 | OS, IS, EE | 6 | [68, 109] |
SYNGAP1 | EE, ID, ASD | >20 | [28, 54, 110, 111] |
TBC1D24 | MPSI, DOORS, EOEE, FE + ID, FIME, PME | >15 | [100, 112–118] |
Metabolism | |||
CERS1 | PME | 1a | [119] |
SLC13A5 | EOEE | 3a | [120] |
SLC25A22 | NEESBs, MPSI, EME | 4a | [121–124] |
SLC35A2 | EOEE, IS | 8 | [68, 125, 126] |
Synaptic vesicle cycle | |||
DNM1 | IS, LGS | 5 | [68] |
NECAP1 | EOEE | 1a | [127] |
SNAP25 | EE | 1 | [128] |
STX1B | Fever-associated epilepsy | 6 | [129] |
STXBP1 | EOEE, OS, IS, DS, EE | >50 | [42, 130–137] |
mTOR signaling | |||
DEPDC5 | FFEVF, ADNFLE, BECTS, FCD, HME | >40 | [58–64] |
MTOR | FCD | 18 | [66, 138] |
Multiple functions | |||
ALG13 | IS, LGS | 4 | [46, 54, 134] |
EEF1A2 | IS, EOEE, ASD, ID, microcephaly | 4 | [54–56] |
PURA | EOEE | 15 | [31, 32] |
WWOX | EOEE, microcephaly | 8a | [139–142] |
ABPE atypical benign partial epilepsy, ADNFLE autosomal dominant nocturnal frontal lobe epilepsy, ASD autism spectrum disorder, BECTS benign epilepsy with centrotemporal spikes, BFNS benign familial neonatal seizures, CAE childhood absence epilepsy, CSWS continuous spike and waves during sleep, DOORS deafness, onychodystrophy, osteodystrophy, mental retardation and seizures syndrome, DS Dravet syndrome, EE epileptic encephalopathy, EME early myoclonic encephalopathy, EOEE early onset epileptic encephalopathy, FE focal epilepsy, FFEVPF familial focal epilepsy with variable foci, FIME familial infantile myoclonic epilepsy, GGE genetic generalized epilepsy, HME hemimegalencephaly, ID intellectual disability, IS infantile spasms, JME juvenile myoclonic epilepsy, LGS Landau–Kleffner syndrome, MAE myoclonic astatic epilepsy, MPSI migrating partial seizures of infancy, NEESBs neonatal epileptic encephalopathy with suppression bursts, OS Ohtahara syndrome, PME progressive myoclonus epilepsy.
aRefers to the number of families for recessive genes or isolated cases with respect to recurrent mutations.
bUnrelated probands have the same recurrent mutation (KCNC1 p.Arg320His), demonstrated to be de novo in 9/13.